Skip to main content
. 2018 Jun 29;12:430. doi: 10.3389/fnins.2018.00430

FIGURE 6.

FIGURE 6

The concentrations of Gal-3 in CSF (ng/mL) of AD patients and healthy controls. AD patients showed enhanced Gal-3 concentrations in CSF as compared to the healthy controls (AD vs. healthy controls [mean ± SD] 8.37 ± 2.79 vs. 5.19 ± 2.23 ng/mL; P = 0.019).